NewsBenzingaCan-Fite BioPharma sagt, dass das EAPO eine Mitteilung über die Bereitschaft zur Erteilung eines Patents ausgestellt hat, das die Verwendung von Piclidenoson zur Behandlung von mit OCRL-Mangel verbundenen Krankheiten abdeckt Can-Fite BioPharma sagt, dass das EAPO eine Mitteilung über die Bereitschaft zur Erteilung eines Patents ausgestellt hat, das die Verwendung von Piclidenoson zur Behandlung von mit OCRL-Mangel verbundenen Krankheiten abdeckt Benzinga 2026.11.02 12:08 (GMT+0) Open on Benzinga Other news Top Wall Street Forecasters Revamp TJX Expectations Ahead Of Q3 Earnings Trump Reportedly Traded Over $97 Million Worth of Nvidia Stock in 2 Years — Elizabeth Warren Wants Congress to Force Him to ‘Divest’ A-Share Market Close: ChiNext Index Rebounds From Lows to Gain 0.85% as Shanghai-Shenzhen Turnover Hits New Low for the Year Nebius Shares Jump After Hours as Nvidia’s Strong Quarterly Numbers Lift AI Infrastructure Stocks Reported Earlier, 'Salesforce Has Started Cutting More Jobs, Internal Messages Show' - Business Insider Stock Market: Will S&P 500 Open Up or Down Today?
Trump Reportedly Traded Over $97 Million Worth of Nvidia Stock in 2 Years — Elizabeth Warren Wants Congress to Force Him to ‘Divest’
A-Share Market Close: ChiNext Index Rebounds From Lows to Gain 0.85% as Shanghai-Shenzhen Turnover Hits New Low for the Year
Reported Earlier, 'Salesforce Has Started Cutting More Jobs, Internal Messages Show' - Business Insider